MeiraGTx Holdings (MGTX) Net Cash Flow (2017 - 2025)
MeiraGTx Holdings (MGTX) posted Net Cash Flow of $50.9 million for Q4 2025, up 491.88% on a QoQ basis from -$13.0 million in Q3 2025, and up 351.21% year-over-year from $11.3 million in Q4 2024.
MeiraGTx Holdings (MGTX) Net Cash Flow (2017 - 2025) Analysis & Trends
MeiraGTx Holdings' Net Cash Flow history runs 9 years deep, the most recent figure standing at $50.9 million for Q4 2025.
- Quarterly Net Cash Flow rose 351.21% year-over-year to $50.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$38.2 million (down 44.23% YoY) and the FY2025 annual result came in at -$38.2 million, down 44.23% from the prior year.
- Net Cash Flow was $50.9 million for Q4 2025 at MeiraGTx Holdings, up from -$13.0 million in the prior quarter.
- Across five years, Net Cash Flow topped out at $64.3 million in Q4 2023 and bottomed at -$47.2 million in Q1 2023.
- A 5-year average of -$7.3 million and a median of -$16.1 million in 2024 frame the typical range for Net Cash Flow.
- Annual changes were most pronounced in 2023 — Net Cash Flow surged 86848.65% — and 2025, when it sank 244.83%.
- MeiraGTx Holdings' Net Cash Flow stood at -$5.2 million in 2021, then jumped by 101.41% to $74000.0 in 2022, then jumped by 86848.65% to $64.3 million in 2023, then sank by 131.47% to -$20.2 million in 2024, then soared by 351.21% to $50.9 million in 2025.
- Business Quant data shows MGTX's Net Cash Flow at $50.9 million in Q4 2025, -$13.0 million in Q3 2025, and -$39.3 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 10.56 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 224.46 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.34 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 457.40 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -152.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 57.19 Mn |
| 10 | MeiraGTx Holdings | 973.21 Mn | 907.27 Mn | - | 50.87 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 50.87 Mn |
| Dec 31, 2025 | 50.87 Mn |
| Sep 30, 2025 | -12.98 Mn |
| Sep 30, 2025 | -12.98 Mn |
| Jun 30, 2025 | -39.29 Mn |
| Jun 30, 2025 | -39.29 Mn |
| Mar 31, 2025 | -36.80 Mn |
| Mar 31, 2025 | -36.80 Mn |
| Dec 31, 2024 | -20.25 Mn |
| Dec 31, 2024 | -20.25 Mn |
| Sep 30, 2024 | 23.62 Mn |
| Sep 30, 2024 | 23.62 Mn |
| Jun 30, 2024 | -19.18 Mn |
| Jun 30, 2024 | -19.18 Mn |
| Mar 31, 2024 | -10.67 Mn |
| Mar 31, 2024 | -10.67 Mn |
| Dec 31, 2023 | 64.34 Mn |
| Dec 31, 2023 | 64.34 Mn |
| Sep 30, 2023 | -28.38 Mn |
| Sep 30, 2023 | -28.38 Mn |